Primary cerebral non-Hodgkin's lymphoma (PCNSL): A review of new trends in management

Italian Journal of Neurological Sciences

Volumn 18, Issue 1, 1997, Pages 1-7

  Boiardi, A ^a   Silvani, A ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

brain lymphoma; chemotherapy; radiotherapy; survival prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYTARABINE; DACARBAZINE; DOXORUBICIN; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

BRAIN LYMPHOMA; CANCER SURVIVAL; CLINICAL FEATURE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NEUROTOXICITY; NONHODGKIN LYMPHOMA; PROGNOSIS; RELAPSE; REVIEW;

BRAIN NEOPLASMS; HUMANS; LYMPHOMA, NON-HODGKIN;

EID: 0030975367     PISSN: 03920461     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02106223     Document Type: Review

References (71)

1. ABELSON H.T., KUFE D.W., SKARIN A.T.: Treatment of central nervous system tumours with methotrexate. Cancer Treat. Rep. 65 (suppl. 1): 137-140, 1981.
2. ALLEN J.C., ROSEN G., MEHTA B.M., HORTEN B.: Leukoencephalopathy following high dose i.v. methotrexate chemotherapy with leucovorin rescue. Cancer Treat. Rep. 64: 1261-1273, 1980.
3. AMBINDER R.F., DUMLER J.S., CHARACHE P.: Detection of Epstein-Barr virus (EBV) DMA in primary central nervous system lymphomas (PCNSL) in patients without history of immunocompromise. Blood 74: (suppl. 1), 120-128, 1989.
4. ASHBY M.A., BARBER P.C., HOLMES A.E., FREER C.E., COLLINS R.: Primary intracranial Hodgkin's disease. A case report and discussion. Am. J. Surg. Pathol. 12: 294299, 1988.
5. BASHIR R., COAKHAM H., HOCHBERG F.: Expression of LFA-l/ICAM-1 in CNS lymphomas: a possible mechanism for lymphoma homing into the brain. J. Neurooncol. 12: 103-110, 1992.
6. BASHIR R.M., HARRIS N.L., HOCHBERG F.H.: Detection of Epstein-Barr virus in CNS lymphomas by in situ hybridisation. Neurology 39: 813-817, 1989.
7. BAUMANN M.A., RITCH P.S., HANDLE K.R.: Treatment of intraocular lymphoma with high-dose Ara-C. Cancer 57: 1273-1277, 1986.
8. BEDNAR M.M., SALERNI A., FLANAGAN M.E., PENDLEBURY W.W.: Primary central nervous system T-cell lymphoma. Case report. J. Neurosurg. 74: 668-672, 1991.
9. BERRY M.P., SIMPSON W.J.: Radiation therapy in the management of primary malignant lymphoma of the brain. J. Rad. Oncol. Biol. Phys. 7: 55-59, 1981.
10. BOGDHAN U., BOGDHAN S., MERTENS H.G., DOMMASCH D., WODARZ R., WUNSCH P.H., KHUL P., RICHTER E.: Primary non-Hodgkin's lymphoma in the CNS. Acta Neurol. Scand. 73: 602-614, 1986.
11. BOIARDI A., SlLVANI A., VALENTINI S., SALMAGGI A., ALLEGRANZA A., BROGGI G.: Chemotherapy as a first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system: preliminary data. J. Neurol. 241: 96-100, 1993.
12. BRADA M., DEARNALEY D., HORWICH A.: Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radiotherapy alone. Int. J. Radiation Oncology Biol. Phys. 18: 787-792, 1990.
13. CHAR D.H., LJUNG B.M., MILLER T.: Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmol. 95: 625-630, 1988.
14. CLARK W.C., CALLIHAN T.T., SCHWARTZERBERG L., 3FONTANESI J.: Primary intracranial Hodgkin's lymphoma without durai attachment. Case report. J. Neurosurg. 76: 692-695, 1992.
15. COHEN I.J., VOGEL R., MATZ S.: Successful non-neurotoxic therapy (without radiation) of a multifocal primary brain lymphoma with a methotrexate, vincristine and BCNU protocol (DEMOB). Cancer 57: 6-11, 1986.
16. DHALBORG S.A., HENNER W.D., GROSSEN J.R.: Non AIDS primary CMS lymphoma: the first example of a durable response in a primary brain tumor using enhanced chemotherapy delivered without cognitive loss and without radiotherapy. Cancer J. Dei. Am. 10: 166-174, 1996.
17. DE ANGELIS L.M.: Primary central nervous system lymphoma (PCNSL) presenting as non-enhancing lesion on MR scan. Neurology 42: (suppl. 3), 389, 1992.
18. DE ANGELIS L.M.: Current management of primary central nervous system lymphoma. Oncology 9: 63-71, 1995.
19. DE ANGELIS L.M.: Primary central nervous system limphoma: a new challenge. Neurology 41: 619-621, 1991.
20. DE ANGELIS L.M., YAHALOM J., HEINEMANN M.H.: Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy. Neurology 40: 80-86, 1990.
21. DE ANGELIS L.M., YAHALOM J., THALER H.T.. Combined modality treatment for primary CNS lymphoma. J. Clin. Oncol. 10: 635-643, 1992.
22. EBY N.L., GRUFFERMAN S., FLANNELLI C.M., SCHOLD S.C., VOGEL S., BURGER P.C.: Increasing incidence of primary CNS lymphoma in the US. Cancer 62: 2461-2465, 1988.
23. ERVIN T., CANELLOS O.P.: Successful treatment of recurrent primary central nervous system lymphoma with highdose methotrexate. Cancer 45: 1556-1557, 1980.
24. FREILICH R.J., DELATRE J.Y., MONJOUR A., DE ANGELIS L.M.: Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 46: 435-439, 1996.
25. GABBAI A.A., HOCHBERG F.H., LINGGOOD R.: High dose methotrexate therapy of primary brain lymphoma. J. Neurosurg. 70: 190-194, 1989.
26. GRANT J.W., ISAACSON P.G.: Primary central nervous system lymphoma. Brain. Pathol. 2: 97-109, 1992.
27. GROTE T.H., GROSH W.W., LIST A.F., WILEY R., CouSAR J.B., JOHNSON D.H.: Primary lymphoma of the central nervous sustem. Am. J. Clin. Oncol. (CCT) 12 (2): 93-100, 1989.
28. HAYAKAWA T., TAKAKURA K., ABE H., YOSHIMOTO T., TANAKA R., SUGITA K., KIKUCHI H., UOZUMI T., HORI T., FUKI H., USHIO Y, NOMURA K., MATSUTAMI M., MOHRI N., KAMANISHI T., AOZASA K., NAGASHIMA K.: Primary central nervous system lymphoma in Japan. A retrospective co-operative study by CNS - Lymphoma Study Group in Japan. J. Neurooncol. 19: 197-215, 1994.
29. HOCHBERG F.H., LOEFFLER J.S., PRADOS M.: The therapy of primary brain lymphoma. J. Neurooncol. 10: 191-201, 1991.
30. HOCHBERG F.H., MOLLER D.C.: Primary central nervous system lymphoma. J. Neurosurg. 68: 835-853, 1988.
31. HOMO-ôELARCH F.. Glucocorticoid receptors and steroid sensitivity in normal and neoplastic human lymphoid tissues. A review. Cancer. Res. 44: 431-437, 1984.
32. JELLINGER K.A., PAULUS W.: Primary central nervous system lymphomas: an update. Cancer Res. Clin. Oncol. 119: 7-27, 1992.
33. JELLINGER K.A., PAULUS W.: Primary central nervous system lymphomas: new pathological developments. J. Neurooncol. 24: 33-36, 1995.
34. KAWAKAMI Y., TABUCHI K., OHNISHI R.: Primary central nervous system lymphoma. J. Neurosurg. 62: 522-527, 1985.
35. LACHANCE D.H., GOCKERMAN J., HALPERIN E.: Cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) for primary central nervous system lymphoma (PCNSL). Short-duration response, multifocal intracerebral recurrence preceding radiotherapy. Neurology 44: 1721-1727, 1994.
36. LACHANCE D.H., O'NEILL B.P., MACüONALD D.R.: Primary leptomeningeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis and review of the literature. Neurology 41: 95-100, 1991.
37. LETENDRE L., BANKS P.M., REESE D.F., MILLER R.H., SCANLON P.W., KIELY J.K.: Primary lymphoma of the central nervous system. Cancer 49: 939-943, 1984.
38. Li C.Y., WITZIG T.E., PHYLIKY R.L.: Diagnosis of B cell non Hodgkin 's lymphoma of the central nervous system by immunocytochemical analysis of cerebrospinal fluid lymphocytes. Cancer 57: 737-744, 1986.
39. LIY H.M., MAUER H.S., VONGSIVUT S., CONWAY J.J.: Methotrexate encephalopathy. Human Pathology, 9: 636649, 1978,
40. LOEFFLER J.S., ERVIN T.J., MAUCH P.: Primary lymphoma of the central nervous system: patterns of failure and factors that influence survival. J. Clin. Oncol. 3: 490494, 1985.
41. MENDENHALL N.P., THAR T.L., AGES O.P.: Primary lymphoma of the nervous system. Cancer 52: 1993-2000, 1983.
42. MERCHUT M.P., HABERLAND C., NAHEEDY M.H.: Long survival of primary cerebral lymphoma with progressive radiation necrosis. Neurology 35: 552-556, 1985.
43. MURRAY K., KUN I., Cox J.: Primary malignant lymphoma of the central nervous system. J. Neurosurg. 65: 600-607, 1986.,
44. NAKHLEH R.E., MANIVEL J.C., KURD E.: Central nervous system lymphomas: immunohistochemical and clinicopathologic study of 26 autopsy cases. Arch. Pathol. Lab. Med. 113: 1050-1056, 1989.
45. NEUWELT E.A., BALABAN E., DIEHL J.: Successful treatment of primary central nervous system lymphoma with chemotherapy after osmotic blood brain barrier opening. Neurosurgery 12: 662-671, 1983.
46. NEUWELT E.A., GOLDMAN D.L., DAHLBORG S.A.: Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: Prolonged survival and preservation of cognitive function. J. Clin. Oncol. 9: 1580-1590, 1991.
47. O'NEILL B.P., FALLON J.R., EARLE J.D., COLGAN J.P., BROWN L.D., KRIGEL R.L.: Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy? Int. J. Radiât. Oncol. Bio Phys. 33: 663-673, 1996.
48. OTT R.J., BRADA M., FLOWER M.A.: Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur. J. Cancer 27: 1356-1361, 1991.
49. PATARROYO M., PRIETO J., RINCON J., TIMONEN T., LUNDBERG C., LlNDBOM L., ASJO B., GABMBERG C.G.: Leukocyte-cell adhesion: A molecular process fundamental in leukocyte physiology. Immunol Rev. 114: 67-108, 1990.
50. PAULUS E., JELLINGER K., HALLAS C. OTT G., MULLERHERMEUNK H.K.: Human Herpes virus-6 and EpsteinBarr virus genome in primary cerebral lymphomas. Neurology 43: 1591-1593, 1993.
51. RAMPEN R.H.J., ANDEL J.G., Sizoo W., VAN UNNIK J.: Radiation therapy in primary non Hodgkin's lymphoma of the CNS. Eur. J. Cancer 16: 177-184, 1980.
52. RAZZAQUE A., PARI K.K.: Human Herpes virus-6: tumourogenicity and tumour infiltrating lymphocytes. Cancer Lett. 61: 111-118, 1992.
53. ROCKWOOD F.J., ZAKOV Z.N., BAY J.W.: Combined malignant lymphoma of the eye and CNS (reticulum-cell sarcoma). J. Neurosurg. 61: 369-374, 1984.
54. RUFF R.L., PETITO C.K., RAWLINSON D.G.: Primary cerebral lymphoma mimicking multiple sclerosis. Arch. Neurol. 36: 598, 1979.
55. SAGERMANN R.H., COLLIER C.H., KING G.A.: Radiation therapy of microgliomas. Radiology 149: 567-570, 1983.
56. SCHULTZ C., SCOTT C., SHERMAN W.: Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine and dexamethasone for primary CNS lymphoma: initial report of Radiation Theraphy Oncology Group Protocol 88-06. J. Clin. Oncol. 14: 556-564, 1996.
57. SELCH M.T., SHIMITZU K.T., DE SALLES A.F., SUTTON C., PARKER R.G.. Primary central nervous system lymphoma. Results at the University of California at Los Angeles and rereview of the literature. Am. J. Clin. Oncol. 17: 286-293, 1994.
58. SELVIN M.L., PIALL E.M., AHERNE G.W. et al.: Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid. J. Clin. Oncol. 1: 546-551, 1983.
59. SINGH A., STOBOS R.J., SINGH MB.: Steroid-induced remission in CNS lymphoma. Neurology 32: 1267-1271, 1982.
60. So Y.T., CHOUCAIR A., DAVIS R.I.: Neoplasms of the central nervous system in acquired immunodeficiency syndrome. In Rosemblum ML., Levy R.M., Bredesen D.E. (Eds.), AIDS and Nervous System. Raven Press, New York, pp. 285-300, 1988.
61. SOCIE G., PIPROT-CHAUFFAT C., SCHLIENGER M.: Primary lymphoma of the central nervous system: an unresolved therapeutic problem. Cancer 65: 322-326, 1990.
62. STEWARD D.J., RUSSELL N., DENNERY M.: Cyclophosphamide, adriamycin and dexamethasone in the treatment of bulky central nervous system lymphomas. J. Neurooncol. 2: 289-291, 1984.
63. STRäUCHEN J.A., DALTON J., FRIEDMAN A.M.: Chemotherapy in management of intraocular lymphoma. Cancer 63: 1918-1924, 1989.
64. TALKANEN ST., RIECHERT R.A., GALLATIN W.M., BARGATZE R.F., WEISSMAN E., BUTCHER E.G.: Homing receptors and the control of lymphocyte migration. Immunol. Rev. 91: 39-60, 1986.
65. TAYLOR C.R., RüSSEL R., LUKES R.J.. An immunohistological study of immunoglobulin content of primary central nervous sustem lymphomas. Cancer 41: 2197-2205, 1978.
66. The non Hodgkin's Lymphoma Pathologic Classification Project: The National Cancer Institute sponsored study of classifications of non-Hodgkin 's lymphomas. Summary and descriptions of a working formulation for clinical usage. Cancer 49: 2112-2139, 1982.
67. THOMAS M, MACPHERSON P.: Computed tomography of intracranial lymphoma. Clinical Radiology 33: 331-337, 1982.
68. VAQUERO J., MARTINEZ R., Rossi E.: Primary cerebral lymphoma: the "ghost tumour". Case report. J. Neurosurg. 60: 174-176, 1984.
69. YOKES E.E., ULTMANN J.E., GOLOMB H.M. et al.: Longterm survival of patients with localized diffuse histiocytic lymphoma. J. Clin. Oncol. 3: 1309-1317, 1985.
70. WOODMAN R., SHIN K., PINEO G.: Primary non-Hodgkin's lymphoma of the brain: a review. Medicine 64: 425430, 1985.
71. ZIMMERMAN R.A.: Central nervous system Lymphoma. Radiologie Clinics of North America 28: 697-721, 1990.